112 related articles for article (PubMed ID: 3391871)
1. Efficacy and tolerability of erythromycin acistrate and erythromycin stearate in acute skin infections of patients with atopic eczema.
Salo OP; Gordin A; Brandt H; Antikainen R
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():101-6. PubMed ID: 3391871
[TBL] [Abstract][Full Text] [Related]
2. Comparison of erythromycin acistrate and enterocoated erythromycin base in acute respiratory infections.
Gordin A; Kalima S; Hulmi S; Mäkelä P; Antikainen R
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():85-92. PubMed ID: 3391879
[TBL] [Abstract][Full Text] [Related]
3. Erythromycin acistrate and enterocoated pellets of erythromycin base in acute respiratory infections of hospitalized conscripts.
Gordin A; Salmi HA; Antikainen R
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():93-9. PubMed ID: 3391881
[TBL] [Abstract][Full Text] [Related]
4. Erythromycin acistrate and erythromycin stearate in the treatment of non-gonococcal urethritis.
Rostila T; Visa K; Gordin A; Antikainen R
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():113-9. PubMed ID: 3391873
[TBL] [Abstract][Full Text] [Related]
5. Treatment of respiratory tract infections with erythromycin acistrate and two formulations of erythromycin base.
Wuolijoki E; Flygare U; Hildén M; Hurme J; Järvinen H; Leskinen J; Pynnönen S; Riikonen A; Salomaa V; Seuri M
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():107-12. PubMed ID: 3391872
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerance of erythromycin acistrate in the treatment of acute exacerbations of chronic bronchitis in the elderly.
Forsén KO; Wikberg R; Lehtonen L
Chemotherapy; 1993; 39(6):443-52. PubMed ID: 8222874
[TBL] [Abstract][Full Text] [Related]
7. Hepatic safety of erythromycin acistrate in 1549 patients with respiratory tract or skin infections.
Lehtonen L; Lankinen KS; Wikberg R; Rita H; Salmi HA; Valtonen V
J Antimicrob Chemother; 1991 Feb; 27(2):233-42. PubMed ID: 1676027
[TBL] [Abstract][Full Text] [Related]
8. Time course of the antibacterial activity of erythromycin stearate and erythromycin acistrate against two Staphylococcus aureus strains in vitro.
Korkeala H; Männistö PT
J Antimicrob Chemother; 1988 Aug; 22(2):127-33. PubMed ID: 3182415
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group.
Daniel R
J Int Med Res; 1991; 19(6):433-45. PubMed ID: 1663466
[TBL] [Abstract][Full Text] [Related]
10. Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia.
Wiesner B; Wilen-Rosenqvist G; Lehtonen L
Arzneimittelforschung; 1993 Sep; 43(9):1014-7. PubMed ID: 8240450
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of erythromycin acistrate (2'-acetyl erythromycin stearate) and erythromycin stearate in experimental infections in mice.
Männistö PT; Hanhijärvi H; Havas A; Vuorela A; Komulainen H; Rauramaa V
J Pharmacol Exp Ther; 1989 Sep; 250(3):1028-33. PubMed ID: 2778707
[TBL] [Abstract][Full Text] [Related]
12. Erythromycin ethylsuccinate, base and acistrate in the treatment of upper respiratory tract infection: two comparative studies of tolerability.
Saloranta P; Roos L; Elonen E; Allonen H
J Antimicrob Chemother; 1989 Sep; 24(3):455-62. PubMed ID: 2808197
[TBL] [Abstract][Full Text] [Related]
13. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial.
Parish LC; Jorizzo JL; Breton JJ; Hirman JW; Scangarella NE; Shawar RM; White SM;
J Am Acad Dermatol; 2006 Dec; 55(6):1003-13. PubMed ID: 17097398
[TBL] [Abstract][Full Text] [Related]
14. Penetration of erythromycin into periapical lesions after repeated doses of erythromycin acistrate and erythromycin stearate: a pilot study.
Tuominen RK; Lehtinen R; Peltola J; Wikberg R; Gordin A; Kokkonen P; Pohto P
Oral Surg Oral Med Oral Pathol; 1991 Jun; 71(6):684-8. PubMed ID: 2062521
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of retapamulin 1% ointment for the treatment of infected atopic dermatitis: a pilot study.
Kircik LH
J Drugs Dermatol; 2012 Jul; 11(7):858-60. PubMed ID: 22777229
[TBL] [Abstract][Full Text] [Related]
16. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
17. Comparative liver toxicity of various erythromycin derivatives in animals.
Viluksela M; Hanhijärvi H; Husband RF; Kosma VM; Collan Y; Männistö PT
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():9-27. PubMed ID: 3391880
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic concentration in suction skin blister fluid and saliva after repeated dosage of erythromycin acistrate and erythromycin base.
Tuominen RK; Männistö PT; Solkinen A; Vuorela A; Pohto P; Haataja H
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():57-65. PubMed ID: 3391876
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of erythromycin, 2'-acetyl erythromycin, and their anhydro forms in plasma and tonsillar tissue after repeated dosage of erythromycin stearate and erythromycin acistrate.
Gordin A; Männistö PT; Antikainen R; Savolainen S; Ylikoski J; Kokkonen P; Rauramaa V
Antimicrob Agents Chemother; 1988 Jul; 32(7):1019-24. PubMed ID: 3190191
[TBL] [Abstract][Full Text] [Related]
20. Effect of erythromycin on the oro-caecal transit time in man.
Lehtola J; Jauhonen P; Kesäniemi A; Wikberg R; Gordin A
Eur J Clin Pharmacol; 1990; 39(6):555-8. PubMed ID: 2095341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
